Abiopharma

Clinical trial NCT05377996 updates: 1. completion date: 2027-05-01 → 2027-12-01 2. primary completion date: 2026-12-01 → 2027-02-01 3. enrollment: 319 → 360 participants

Clinical trial NCT06627647 updates: 1. completion date: 2030-03-25 → 2030-11-18 2. primary completion date: 2029-05-10 → 2030-11-18

Clinical trial NCT03919292: status: RECRUITING → SUSPENDED.

Clinical trial NCT06970743 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 150 → 153 participants

Clinical trial NCT05721404 updates: 1. completion date: 2025-12-31 → 2027-12-31 2. primary completion date: 2025-04-28 → 2027-04-28

Clinical trial NCT06851559 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-03-01 → 2027-01-01 3. primary completion date: 2026-12-01 → 2026-10-01 4. enrollment: 80 → 95 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05101356 updates: 1. status: RECRUITING → SUSPENDED 2. start date: 2021-10-13 → 2021-01-13 3. completion date: 2030-01-01 → 2034-01-01 4. primary completion date: 2026-01-01 → 2030-12-31

Clinical trial NCT07651865: collaborators added: Stockholm University.

Clinical trial NCT06241430 updates: 1. completion date: 2027-11-01 → 2030-06-01 2. primary completion date: 2026-11-01 → 2030-06-01 3. collaborators added: National Heart, Lung, and Blood Institute (NHLBI)

Clinical trial NCT07660731 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-03-30 → 2027-06-18 3. primary completion date: 2027-03-30 → 2027-06-18